446 related articles for article (PubMed ID: 1716974)
21. Two different maturational stages of natural killer lymphocytes in human newborn infants.
Sancho L; de la Hera A; Casas J; Vaquer S; Martínez C; Alvarez-Mon M
J Pediatr; 1991 Sep; 119(3):446-54. PubMed ID: 1715396
[TBL] [Abstract][Full Text] [Related]
22. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA
J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571
[TBL] [Abstract][Full Text] [Related]
23. Human first-trimester trophoblast cells recruit CD56brightCD16- NK cells into decidua by way of expressing and secreting of CXCL12/stromal cell-derived factor 1.
Wu X; Jin LP; Yuan MM; Zhu Y; Wang MY; Li DJ
J Immunol; 2005 Jul; 175(1):61-8. PubMed ID: 15972632
[TBL] [Abstract][Full Text] [Related]
24. [Characterization of peripheral blood natural killer (NK) cells in two patients with CD16+ CD56- NK cell-lineage granular lymphocyte-proliferative disorder].
Egashira M; Kaneko T; Oshimi K; Mizoguchi H; Ishida M
Rinsho Ketsueki; 1995 Feb; 36(2):69-75. PubMed ID: 7536278
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic profiles of peripheral blood lymphocytes on the day of embryo transfer in women undergoing in vitro fertilization.
Baczkowski T; Kurzawa R
Folia Histochem Cytobiol; 2007; 45 Suppl 1():S73-7. PubMed ID: 18292839
[TBL] [Abstract][Full Text] [Related]
26. Glycodelin-A stimulates the conversion of human peripheral blood CD16-CD56bright NK cell to a decidual NK cell-like phenotype.
Lee CL; Vijayan M; Wang X; Lam KKW; Koistinen H; Seppala M; Li RHW; Ng EHY; Yeung WSB; Chiu PCN
Hum Reprod; 2019 Apr; 34(4):689-701. PubMed ID: 30597092
[TBL] [Abstract][Full Text] [Related]
27. The immune potential of decidua-resident CD16
Zhang J; Lye SJ
Hum Immunol; 2021 May; 82(5):332-339. PubMed ID: 33583640
[TBL] [Abstract][Full Text] [Related]
28. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
[TBL] [Abstract][Full Text] [Related]
29. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.
Caligiuri MA; Murray C; Robertson MJ; Wang E; Cochran K; Cameron C; Schow P; Ross ME; Klumpp TR; Soiffer RJ
J Clin Invest; 1993 Jan; 91(1):123-32. PubMed ID: 7678599
[TBL] [Abstract][Full Text] [Related]
30. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.
Carson WE; Fehniger TA; Caligiuri MA
Eur J Immunol; 1997 Feb; 27(2):354-60. PubMed ID: 9045904
[TBL] [Abstract][Full Text] [Related]
31. NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.
Keever CA; Pekle K; Gazzola MV; Collins NH; Gillio A
Cell Immunol; 1990 Mar; 126(1):211-26. PubMed ID: 1689220
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
Naume B; Gately M; Espevik T
J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169
[TBL] [Abstract][Full Text] [Related]
33. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
[TBL] [Abstract][Full Text] [Related]
34. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
35. Decidual stromal cells promote the differentiation of CD56
Yang HL; Zhou WJ; Lu H; Lei ST; Ha SY; Lai ZZ; Zheng ZM; Ruan LY; He YY; Li DJ; Li MQ; Shao J
Am J Reprod Immunol; 2019 Jun; 81(6):e13110. PubMed ID: 30903677
[TBL] [Abstract][Full Text] [Related]
36. Cell populations in the human early pregnancy decidua: natural killer activity and response to interleukin-2 of CD56-positive large granular lymphocytes.
Ferry BL; Starkey PM; Sargent IL; Watt GM; Jackson M; Redman CW
Immunology; 1990 Aug; 70(4):446-52. PubMed ID: 1697563
[TBL] [Abstract][Full Text] [Related]
37. Human fetal liver-derived CD7+CD2lowCD3-CD56- clones that express CD3 gamma, delta, and epsilon and proliferate in response to interleukin-2 (IL-2), IL-3, IL-4, or IL-7: implications for the relationship between T and natural killer cells.
Hori T; Phillips JH; Duncan B; Lanier LL; Spits H
Blood; 1992 Sep; 80(5):1270-8. PubMed ID: 1381242
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: the FcR gamma III (CD16) molecule and NK cell differentiation.
Warren HS; Skipsey LJ
Immunology; 1991 Jan; 72(1):150-7. PubMed ID: 1825480
[TBL] [Abstract][Full Text] [Related]
39. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases.
Borrego F; Peña J; Solana R
Eur J Immunol; 1993 May; 23(5):1039-43. PubMed ID: 8477800
[TBL] [Abstract][Full Text] [Related]
40. Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua.
Saito S; Nishikawa K; Morii T; Enomoto M; Narita N; Motoyoshi K; Ichijo M
Int Immunol; 1993 May; 5(5):559-63. PubMed ID: 7686393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
